Browse Drug Recalls
35 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 35 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 35 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 26, 2023 | Lidocaine Ointment USP, 5%, 1 1/4 oz tubes, Rx Only, Manufactured for: HI-TEC... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Fluticasone Propionate Nasal Spray, 50mcg, 16 g bottles, Manufactured by: HI-... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Guaifenesin Oral Solution, 300 mg/ 15 mL, Sugar Free/Alcohol Free, Rx Only, F... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Lidocaine 2.5% & Prilocaine 2.5% Cream, 30 gram tubes, Rx Only, Manufactured ... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Azelastine Hydrochloride Nasal Spray, 0.15%, 105.5 mcg per spray, Rx Only, Fo... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Aug 1, 2022 | PrednisoLONE Oral Solution USP, 15 mg per 5 mL, 240 ml bottle, Rx Only, HI-TE... | Defective Container: Product has incomplete induction seals. | Class II | Akorn, Inc |
| Jun 13, 2022 | Fluticasone Propionate Nasal Spray, USP, 50 mcg, 16 g net fill weight per amb... | Defective container: defect prevents product from dispensing as intended. | Class II | Akorn, Inc. |
| Jun 10, 2022 | Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only, 60 mL (2 fl... | Defective Delivery System: Potential defect that could prevent the product from dispensing as int... | Class II | Akorn, Inc. |
| Apr 15, 2022 | Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per b... | Failed viscosity specification - product was below specificcation | Class III | Akorn, Inc. |
| Mar 15, 2022 | Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufact... | cGMP deviations: all products within expiry are being recalled because the firm is discontinuing ... | Class II | Teligent Pharma, Inc. |
| Dec 3, 2021 | Oxycodone Hydrochloride Oral Solution, USP 5 mg per 5 mL (1 mg/mL), 500 mL bo... | Labeling: Missing Label | Class III | Akorn, Inc. |
| Dec 3, 2021 | Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) 30 mL bottles, Rx o... | Labeling: Missing Label | Class III | Akorn, Inc. |
| Dec 28, 2020 | Levetiracetam Oral Solution, 100 mg/mL, 16 fl oz (473 mL) bottle, Rx Only, HI... | Defective container: Customer complaints for oral solution leaking from bottles. | Class II | Akorn, Inc. |
| Jun 5, 2020 | Prednisolone Sodium Phosphate Oral Solution, 5 mg/5 mL, 120 mL Bottle, Rx onl... | Discoloration: Out of Specification (OOS) result for APHA Color Test. | Class III | Akorn, Inc. |
| Dec 16, 2019 | Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx o... | Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of th... | Class II | Akorn Inc |
| Mar 28, 2019 | Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx on... | Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was ob... | Class III | Akorn, Inc. |
| Aug 1, 2018 | Lidocaine 2.5% and Prilocaine Cream, 2.5%. 30g tube, Rx only, Manufactured by... | Failed Impurities/Degredation Specifications: Out of Specification results for an unknown impuri... | Class II | Akorn, Inc. |
| Mar 29, 2018 | Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-72... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Mar 29, 2018 | 24-HOUR Oral Care q4 Kit with Ballard* Technology, containing 2 Toothbrush Pa... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Mar 29, 2018 | 24-HOUR Oral Care q2 Kit with Ballard* Technology, containing 2 Toothbrush Pa... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Dec 15, 2017 | Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bo... | CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufact... | Class III | Akorn Inc |
| Feb 7, 2017 | Levofloxacin Ophthalmic Solution, 0.5%, Sterile, packaged in 5mL bottles, Rx... | Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at... | Class III | Actavis Inc |
| Jun 1, 2016 | CHLORHEXIDINE GLUCO. 0.12% ORAL RINSE, Packaged in 473 ML Bottles, Rx Only. ... | Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity. | Class II | Aidarex Pharmaceuticals LLC |
| Jun 1, 2016 | Ciprofloxacin OPTH 0.3% SOL, generic for: Ciloxan, Rx Only, 2.5 mL Bottle, ... | Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity. | Class III | Aidarex Pharmaceuticals LLC |
| Mar 23, 2016 | Chlorhexidine gluconate, oral rinse, 0.12% packaged in 16 fl. oz. (473 mL) PE... | Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) ... | Class II | Akorn, Inc. |
| Apr 7, 2015 | Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) b... | Failed Impurities/Degradation Specifications | Class II | Akorn, Inc. |
| Apr 7, 2015 | Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) b... | Failed Impurities/Degradation Specifications | Class II | Akorn, Inc. |
| Feb 27, 2015 | Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, in amber glass bo... | Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride. | Class II | Akorn, Inc. |
| Apr 1, 2014 | HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg / 5mL, Net Wt 16 fl oz (4... | Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown... | Class II | Hi-Tech Pharmacal Co., Inc. |
| Oct 28, 2013 | Acyclovir Oral Suspension, USP 200 mg/5 mL, Net Wt. 16 fl oz (473 mL), Rx onl... | Failed Stability Specification; product viscosity and or pH are below specification. | Class III | Hi-Tech Pharmacal Co., Inc. |
| Sep 4, 2013 | GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 1 fl. oz. (NDC 58552-... | Subpotent; phenylephrine HCl | Class III | Hi-Tech Pharmacal Co., Inc. |
| Jul 25, 2013 | Clobetasol Propionate Cream, USP, 0.05%, 15 grams, Rx only, Hi-Tech PHARMACAL... | Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes lab... | Class III | Hi-Tech Pharmacal Co., Inc. |
| Apr 30, 2013 | HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL)... | Subpotent; 24 month stability test station | Class III | Hi-Tech Pharmacal Co., Inc. |
| Apr 8, 2013 | BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 m... | Subpotent; Cetylpyridinum Chloride | Class III | Hi-Tech Pharmacal Co., Inc. |
| Mar 11, 2013 | Acetic Acid Otic Solution, USP, 15 mL bottle, Rx Only, Hi-Tech Pharmacal Co.,... | Subpotent Drug: The product/lot is out-of-specification (OOS) for the assay of acetic acid at the... | Class III | Hi-Tech Pharmacal Co., Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.